Breast Cancer, Surgery
Conditions
Brief summary
Evaluate the impact of coaching sessions on the return to work rate (number of patients returning at work / total number of patients per arm) 6 months after inclusion in the study for breast cancer in professionnally active patients.
Interventions
OTHERCoaching sessions
There are 3 sessions : the first session will last 1h30 and will be in consultation within the Institut Curie. The second session will last 1h30 and will be done remotely (by phone or by videoconference). The duration of the 3rd and last session will be adapted according to the needs of each patient and will last a maximum of 1 hour. It will also be done remotely (by phone or by videoconference).
Sponsors
Institut Curie
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Eligibility
Sex/Gender
FEMALE
Age
18 Years to 60 Years
Healthy volunteers
No
Inclusion criteria
Any patient active at the time of the diagnosis of breast cancer, treated consecutively at the Institut Curie during the study period, and whose first treatment will be surgery, will be offered participation in the study. 1. Invasive non-metastatic breast cancer, treated first by surgery 2. Age ≥ 18 and ≤ 60 years 3. Active woman at the time of diagnosis 4. Patient with internet access and email address 5. Patient affiliated with a social security scheme, speaking and reading French 6. Signature of informed consent
Exclusion criteria
1. In situ breast cancer 2. History of breast cancer 3. Metastatic breast cancer 4. Inflammatory Breast Cancer 5. Woman with a life expectancy \<6 months at the time of diagnosis (in relation to other serious chronic diseases) 6. Persons deprived of liberty or under guardianship 7. Impossibility to submit to the medical follow-up of the test for geographical, social or psychological reasons
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Impact of coaching sessions on the return to work rate (number of patients returning at work / total number of patients per arm) 6 months after inclusion in the study | 6 months | The rate of patients returning to work (part-time or full-time) for more than 2 weeks to 6 months of inclusion in the study in each group. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Sustainability of the return to work | 6 and 12 months | Evaluation of the durability of the return to work at 6 and 12 months after inclusion by registration by the patients of the number of days off work and / or working time arrangement |
| Impact of the return to work / work stoppage on the quality of life | 6 and 12 months | Evaluation of the impact of return to work / work stoppage on the quality of life estimated by QLQ-C30 questionnaire at baseline and at 6 and 12 months post-inclusion |
| Quality of the return to work | 6 and 12 months | Evaluation of the quality of the return to work at 6 and 12 months after inclusion by questionnaire VOW / QFT (in case of return to work only). Evaluation scale : 1=never to 4=ever |
| The determinants of return to work (factors associated with a return to work successful: early, sustainable and quality) | 12 months | Determining the determinants of return to work at 6 and 12 months post inclusion using the QLQ-BR23questionnaire. Evaluation scale : 0=not at all to 4=a lot |
| The medico-economic impact of returning to work | 12 months | Evaluation of the medico-economic impact of return to work by comparing the costs of care in the two groups |
| The production losses related to presenteeism during maintenance or return to work | 6 and 12 months | Evaluation of production losses related to presenteeism at the time of maintenance or return to work at 6 and 12 months post inclusion, by collecting the number of days worked during the study period (12 months) |
Countries
France
Outcome results
None listed